RESUMEN
Constrictive pericarditis most commonly results from fibrosis and adhesions of the parietal and visceral pericardium due to long-standing inflammation. Common etiologies include idiopathic, post-surgical, radiation injury and infectious etiologies including tuberculosis. Traumatic hemopericardium is a rare cause of constrictive pericarditis but atraumatic hemopericardium causing constrictive pericarditis has not been reported in the literature to date. We present a case of constrictive pericarditis from an atraumatic hemopericardium after systemic thrombolysis for a massive pulmonary embolism.
RESUMEN
SOURCE CITATION: GRADE Study Research Group; Nathan DM, Lachin JM, Balasubramanyam A, et al. Glycemia reduction in type 2 diabetes-glycemic outcomes. N Engl J Med. 2022;387:1063-74. 36129996.
Asunto(s)
Diabetes Mellitus Tipo 2 , Metformina , Humanos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insulina Glargina/uso terapéutico , Fosfato de Sitagliptina/uso terapéutico , Liraglutida/uso terapéutico , Hipoglucemiantes/uso terapéutico , Resultado del Tratamiento , Quimioterapia Combinada , Glucemia , Metformina/uso terapéuticoRESUMEN
SOURCE CITATION: GRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997.
Asunto(s)
Diabetes Mellitus Tipo 2 , Humanos , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Insulina Glargina/uso terapéutico , Liraglutida/uso terapéutico , Fosfato de Sitagliptina/uso terapéutico , Hipoglucemiantes/uso terapéutico , Quimioterapia Combinada , Resultado del TratamientoRESUMEN
SOURCE CITATION: Fischer U, Kaesmacher J, Strbian D, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400:104-15. 35810756.
Asunto(s)
Accidente Cerebrovascular Isquémico , Humanos , Estado Funcional , Accidente Cerebrovascular Isquémico/tratamiento farmacológico , Accidente Cerebrovascular Isquémico/cirugía , Activador de Tejido Plasminógeno/uso terapéutico , Resultado del Tratamiento , Estudios de Equivalencia como Asunto , Ensayos Clínicos Controlados Aleatorios como Asunto , TrombectomíaRESUMEN
SOURCE CITATION: Joseph P, Roshandel G, Gao P, et al. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet. 2021;398:1133-46. 34469765.
Asunto(s)
Enfermedades Cardiovasculares , Aspirina/uso terapéutico , Enfermedades Cardiovasculares/prevención & control , Combinación de Medicamentos , Humanos , Prevención PrimariaRESUMEN
SOURCE CITATION: Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385:790-802. 34351721.
Asunto(s)
COVID-19 , Anticoagulantes/uso terapéutico , Heparina , Humanos , Alta del Paciente , SARS-CoV-2RESUMEN
SOURCE CITATION: Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385:777-89. 34351722.
Asunto(s)
COVID-19 , Enfermedad Crítica , Anticoagulantes/efectos adversos , Heparina/efectos adversos , Humanos , SARS-CoV-2RESUMEN
SOURCE CITATION: Jankowska EA, Kirwan BA, Kosiborod M, et al. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. Eur Heart J. 2021;42:3011-20. 34080008.
Asunto(s)
Anemia Ferropénica , Insuficiencia Cardíaca , Anemia Ferropénica/tratamiento farmacológico , Compuestos Férricos , Humanos , Maltosa/análogos & derivados , Calidad de VidaRESUMEN
A 76-year-old man with hypogammaglobulinemia on monthly intravenous immunoglobulin infusions presented to the hospital with fever, cough, and shortness of breath and was diagnosed with COVID-19 pneumonia requiring intensive care unit admission but not intubation. He was treated with convalescent plasma, remdesivir and corticosteroids. Sixteen days into his hospitalisation he began to report weakness without sensory symptoms and was found on biopsy to have a necrotising myopathy.
Asunto(s)
COVID-19 , Enfermedades Musculares , Tiroiditis , Anciano , COVID-19/terapia , Humanos , Inmunización Pasiva , Masculino , SARS-CoV-2 , Sueroterapia para COVID-19RESUMEN
SOURCE CITATION: Baek SH, Jo YH, Ahn S, et al. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial. JAMA Intern Med. 2021;181:81-92. 33104189.
Asunto(s)
Hiponatremia , Humanos , Hiponatremia/inducido químicamente , Hiponatremia/terapia , Factores de Riesgo , Solución Salina Hipertónica , SodioRESUMEN
Infective endocarditis (IE) is a rare complication in pregnancy that is associated with significant morbidity and mortality to both mother and fetus. We present a case of a 27-year-old female at 22-weeks gestation with a history of intravenous drug abuse (IVDA) who developed methicillin sensitive Staphylococcus aureus tricuspid valve endocarditis with persistent bacteremia and septic emboli necessitating tricuspid valve extirpation. Four days later, worsening decompensated heart failure required cesarean section at 23w5d. Although the patient's volume status and dyspnea improved significantly, fetal demise occurred 9 days after operative delivery.
RESUMEN
SOURCE CITATION: Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the treatment of Covid-19-preliminary report. N Engl J Med. 2020. [Epub ahead of print]. 32445440.
Asunto(s)
Adenosina Monofosfato/análogos & derivados , Alanina/análogos & derivados , Antivirales/uso terapéutico , Infecciones por Coronavirus/tratamiento farmacológico , Neumonía Viral/tratamiento farmacológico , Adenosina Monofosfato/uso terapéutico , Adolescente , Adulto , Alanina/uso terapéutico , Betacoronavirus , COVID-19 , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Multicéntricos como Asunto , Pandemias , Ensayos Clínicos Controlados Aleatorios como Asunto , SARS-CoV-2RESUMEN
SOURCE CITATION: Ye Z, Rochwerg B, Wang Y, et al. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020;192:E536-45. 32350002.
Asunto(s)
Infecciones por Coronavirus/terapia , Neumonía Viral/terapia , Corticoesteroides/uso terapéutico , Antivirales/uso terapéutico , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/inmunología , Humanos , Inmunización Pasiva/métodos , Pandemias , Plasma , Neumonía Viral/inmunología , SARS-CoV-2 , Índice de Severidad de la Enfermedad , Sueroterapia para COVID-19RESUMEN
BACKGROUND This article describes a finding of sputum culture positive for Stenotrophomonas maltophilia in an elderly woman with past medical history of chronic obstructive pulmonary disease (COPD) and hypertension, presenting with acute hypoxemic hypercapnic respiratory failure secondary to COPD exacerbation from bronchitis/bronchopneumonia. CASE REPORT Computed tomography (CT) of the chest showed secretions in the lower lobe bronchi and small scattered clustered nodules consistent with bronchitis/mild bronchopneumonia without evidence of pulmonary embolism. A sputum culture was positive for Stenotrophomonas maltophilia. She was treated with trimethoprim/sulfamethoxazole for 10 days. She recovered and was subsequently discharged from the hospital. CONCLUSIONS Stenotrophomonas maltophilia, previously known as a colonizer, is now being recognized as a true respiratory infection, especially in immunocompromised patients and those with chronic diseases like COPD presenting with signs and symptoms of infection. Therefore, early identification and prompt treatment of Stenotrophomonas maltophilia infection is important for a favorable outcome.
Asunto(s)
Infecciones por Bacterias Gramnegativas/diagnóstico , Enfermedad Pulmonar Obstructiva Crónica/microbiología , Anciano , Antibacterianos/uso terapéutico , Diagnóstico Diferencial , Femenino , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/microbiología , Humanos , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Stenotrophomonas maltophilia/aislamiento & purificación , Resultado del Tratamiento , Combinación Trimetoprim y Sulfametoxazol/uso terapéuticoRESUMEN
SOURCE CITATION: Duceppe E, Patel A, Chan MTV, et al. Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery: a cohort study. Ann Intern Med. 2020;172:96-104. 31869834.
Asunto(s)
Enfermedades Cardiovasculares , Péptido Natriurético Encefálico , Biomarcadores , Estudios de Cohortes , Humanos , Fragmentos de Péptidos , Valor Predictivo de las Pruebas , Factores de RiesgoRESUMEN
SOURCE CITATION: Yao P, Bennett D, Mafham M, et al. Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open. 2019;2:e1917789. 31860103.
Asunto(s)
Calcio , Vitamina D , Calcio de la Dieta , Suplementos Dietéticos , VitaminasRESUMEN
AIMS: Despite recent advances in guideline-directed therapy, rehospitalization rates for acute decompensated heart failure (ADHF) remain high. Recently published studies demonstrated the emerging role of hypochloraemia as a predictor of poor outcomes in patients with ADHF. This study sought to determine the correlation between low serum chloride and 30 day hospital readmission in patients with ADHF. METHODS AND RESULTS: We retrospectively reviewed electronic medical records of 1504 patients who were admitted to one 700 bed US tertiary care centre with the diagnosis of ADHF between June 2013 and December 2014. Of the 1504 reviewed records, 1241 were selected for further analysis. Hypochloraemia (either on admission or at discharge) was identified in 289 patients (23.3%) and was associated with significantly higher 30 day hospital readmission rate or death (42.2% vs. 33.7%, P = 0.008). This association persisted in multivariate analysis when controlling for serum sodium, weight loss, diuretic dose, adjunct thiazide use, serum blood urea nitrogen, and BNP levels (OR: 1.35, 95% CI: 1.02-1.77, P = 0.033); however, the predictive value of the overall model was low (Naglkerke R2 = 0.040). Hypochloraemia was also found to be associated with increased 12 month mortality in our cohort (31.4% vs. 20.2%, P = 0.015) that correlates with the results of previously published studies. CONCLUSIONS: Low serum chloride measured in patients admitted for ADHF is independently but weakly associated with increased 30 day readmission rate and demonstrated low predictive value as a potential biomarker in this cohort.
Asunto(s)
Insuficiencia Cardíaca , Readmisión del Paciente , Enfermedad Aguda , Insuficiencia Cardíaca/epidemiología , Humanos , Alta del Paciente , Estudios RetrospectivosRESUMEN
Programmed cell death-1 (PD-1) inhibitors stimulate immune recognition of tumour cells in cancer patients, but have significant autoimmune side effects including pneumonitis. We report the case of a patient with asthma and mild eosinophilia who developed unusual pulmonary side effect of bronchiectasis, severe eosinophilia (absolute eosinophil count: 3200 c/mm3) and elevated IgE levels (7050 IU/mL; normal: <164 IU/mL) 4 months into therapy with the PD-1 inhibitor pembrolizumab. Aspergillus fumigatus IgG was elevated at 15.60 U/mL (normal: <12.01 U/mL). He responded to therapy with corticosteroids and voriconazole and was able to resume pembrolizumab thereafter with good clinical response.